放射性肝段切除术与经动脉化疗栓塞联合微波消融治疗不可切除的3厘米以下孤立性肝细胞癌:倾向性评分匹配研究
这项回顾性研究比较了放射性肝段切除术(RS)与经动脉化疗栓塞(TACE)联合微波消融(MWA)治疗不可切除的3厘米以下孤立性肝细胞癌的疗效。匹配前RS组并发症发生率为4.9%,TACE MWA组为8.9%(P=0.46),总体完全缓解率RS组为82.9%,TACE MWA组为82.5%(OR=1.0,95%CI 0.4-2.8,P=0.95)。中位至进展时间RS组为11.1个月(95%CI 8.8-25.6个月),TACE MWA组为12.1个月(95%CI 7.7-19.1个月)(P>0.99)。匹配后两组的总体完全缓解率(P=0.94)、至进展时间(P=0.83)和总生存期(P>0.99)均无显著差异。两组90天术后死亡率均为0%。作者结论认为,对于3厘米以下孤立性肝细胞癌,RS的影像学反应和进展结局与TACE MWA相比无显著差异。
要点
- 匹配前RS组并发症发生率4.9%,TACE MWA组8.9%,P=0.46
- 匹配前总体完全缓解率RS组82.9%,TACE MWA组82.5%,OR=1.0(95%CI 0.4-2.8),P=0.95
- 匹配后两组完全缓解率(P=0.94)、至进展时间(P=0.83)、总生存期(P>0.99)均无显著差异
核心结论
- 对于3厘米以下孤立性肝细胞癌,RS的影像学反应和进展结局与TACE MWA相比无显著差异。
研究设计与样本
- 回顾性研究,经机构审查委员会批准并豁免知情同意;2010年1月至2015年6月共417例和235例连续肝细胞癌患者分别接受RS和TACE MWA;回顾性识别出121例既往未接受局部区域治疗、无血管侵犯或转移的3厘米以下孤立性肝细胞癌患者(RS组41例,TACE MWA组80例;平均年龄65.4岁;男性84例[69.4%])。采用最近邻算法(1:1)进行倾向性评分匹配,匹配后二分类结局采用条件logistic回归分析,时间依赖性结局采用分层log-rank检验。
诊断标准与关键数值
- 匹配前并发症发生率:TACE MWA组8.9%,RS组4.9%(P=0.46)
- 匹配前总体完全缓解率:RS组82.9%,TACE MWA组82.5%(OR=1.0,95%CI 0.4-2.8,P=0.95)
- 匹配前中位总体至进展时间:RS组11.1个月(95%CI 8.8-25.6个月),TACE MWA组12.1个月(95%CI 7.7-19.1个月)(P>0.99)
- 匹配后总体完全缓解率(P=0.94)、至进展时间(P=0.83)和总生存期(P>0.99)两组间无显著差异
- 90天术后死亡率:两组均为0%
临床应用与阅片要点
- 对于3厘米以下孤立性肝细胞癌,RS与TACE MWA的影像学反应和进展结局无显著差异,阅片评估完全缓解和进展时需结合具体治疗方式。
- 初始完全缓解后进展共41例(RS组11例,TACE MWA组30例),其中靶病灶进展10例(24%)(RS组1例,TACE MWA组9例)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To compare the outcomes of radiation segmentectomy (RS) and transarterial chemoembolization (TACE) combined with microwave ablation (MWA) in the treatment of unresectable solitary hepatocellular carcinoma (HCC) up to 3 cm. Materials and Methods This retrospective study was approved by the institutional review board, and the requirement to obtain informed consent was waived. From January 2010 to June 2015, a total of 417 and 235 consecutive patients with HCC underwent RS and TACE MWA, respectively. A cohort of 121 patients who had not previously undergone local-regional therapy (RS, 41; TACE MWA, 80; mean age, 65.4 years; 84 men [69.4%]) and who had solitary HCC up to 3 cm without vascular invasion or metastasis was retrospectively identified. Outcomes analyzed included procedure-related complications, laboratory toxicity levels, imaging response, time to progression (TTP), 90-day mortality, and survival. Propensity score matching was conducted by using a nearest-neighbor algorithm (1:1) to account for pretreatment clinical, laboratory, and imaging covariates. Postmatching statistical analysis was performed with conditional logistic regression for binary outcomes and the stratified log-rank test for time-dependent outcomes. Results Before matching, the complication rate was 8.9% and 4.9% in the TACE MWA and RS groups, respectively (P = .46). The overall complete response (CR) rate was 82.9% for RS and 82.5% for TACE MWA (odds ratio, 1.0; 95% confidence interval [CI]: 0.4, 2.8; P = .95). There were 41 (RS, 11; TACE MWA, 30) instances of progression occurring after an initial CR, of which 10 (24%) were classified as target progression (RS, one; TACE MWA, nine). Median overall TTP was 11.1 months (95% CI: 8.8 months, 25.6 months) in the RS group and 12.1 months (95% CI: 7.7 months, 19.1 months) in the TACE MWA group (P > .99). After matching, the overall CR rate (P = .94), TTP (P = .83), and overall survival (P > .99) were not significantly different between the two groups. The 90-day postoperative mortality rate was 0% in both groups. Conclusion Imaging response and progression outcomes of patients with solitary HCC up to 3 cm treated with RS were not significantly different when compared with those of patients treated with TACE MWA. © RSNA, 2016 Online supplemental material is available for this article.
引用
- Biederman DM, Titano JJ, Bishay VL, et al. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study. Radiology. 2016. PMID: 27930089. doi:10.1148/radiol.2016160718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。